Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Quest Diagnostics, Inc. shares valued at $5,044,516 were sold by PREVOZNIK MICHAEL E on Aug 29 ’24. At $154.97 per share, PREVOZNIK MICHAEL E sold 32,551 shares. The insider’s holdings dropped to 38,478 shares worth approximately $5.85 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, KUPPUSAMY KARTHIK sold 1,990 shares, netting a total of over 304,990 in proceeds. Following the sale of shares at $153.26 each, the insider now holds 11,459 shares.
Before that, PREVOZNIK MICHAEL E had added 32,551 shares to its account. In a trade valued at $5,044,516, the Officer bought Quest Diagnostics, Inc. shares for $154.97 each.
Analysts at Citigroup upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early July. As of February 26, 2024, Leerink Partners has initiated its “Market perform” rating for DGX. Earlier on February 07, 2024, Jefferies upgraded its rating. Their new recommendation was “a Buy” for DGX stock which previously was a “a Hold”.
Analyzing DGX Stock Performance
During the last five days, there has been a drop of approximately -1.48%. Over the course of the year, Quest Diagnostics, Inc. shares have jumped approximately 10.34%. Shares of the company reached a 52-week high of $159.36 on 09/04/24 and a 52-week low of $123.04 on 02/01/24. A 50-day SMA is recorded $151.84, while a 200-day SMA reached $138.95. Nevertheless, trading volume fell to 0.56 million shares from 0.58 million shares the previous day.
Support And Resistance Levels for Quest Diagnostics, Inc. (DGX)
According to the 24-hour chart, there is a support level at 150.92, which, if violated, would cause prices to drop to 149.70. In the upper region, resistance lies at 154.22. The next price resistance is at 156.30. RSI (Relative Strength Index) is 45.37 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.66, which suggests the price will decrease in the coming days. Percent R is at 93.75%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
